**Core Concept:** Pancuronium is a neuromuscular blocking agent (NMBAs) used during general anaesthesia to facilitate endotracheal intubation by blocking the neuromuscular junction. NMBA drugs work by inhibiting the release of acetylcholine, which leads to muscle relaxation and immobilization.

**Why the Correct Answer is Right:** Pancuronium is a steroid-derived NMBAs, which have a rapid onset and long duration of action compared to other NMBAs like atracurium or rocuronium. During intubation, a dose of pancuronium is used to facilitate the procedure by paralyzing the patient, allowing the intubation team to insert the endotracheal tube without struggling against muscle contractions. The optimal dose of pancuronium for intubation is usually 0.1 mg/kg, which ensures adequate relaxation without causing excessive paralysis or respiratory depression.

**Why Each Wrong Option is Incorrect:**

A. 0.1 mg/kg: Although this dose is correct for a general anaesthetic induction, it is not the optimal dose for intubation. A higher dose may lead to excessive muscle relaxation and potential respiratory depression.

B. 0.2 mg/kg: This dose is too high and may cause respiratory depression, which is risky during intubation.

C. 0.4 mg/kg: This dose is too high, leading to excessive muscle relaxation and potential respiratory depression, which is not suitable for intubation purposes.

D. 0.6 mg/kg: This dose is too high and may cause respiratory depression, making it unsuitable for intubation purposes.

**Clinical Pearl:** It is crucial to use the appropriate dosage of pancuronium for intubation. Overestimating or underestimating the dose can lead to either insufficient muscle relaxation or respiratory complications. The optimal dose for intubation is 0.1 mg/kg, ensuring adequate muscle relaxation without causing adverse effects.